EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA

Xiao Xu iD, Xiang Wang iD, Yu-Pei Liao iD, Lijia Luo iD, Andre E Nel iD

ACS Nano · 11.03.2025 · 19 (9) · 8579-8594

DOI: 10.1021/acsnano.4c14102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 03.03.2025. Verfasst von Xiao Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Membrane Proteins, Nanoparticles. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Marlin Miller Jr Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Membrane ProteinsNanoparticlesRNA, MessengerLipidsAnimalsMiceHumansCell Line, TumorNucleotides, CyclicMice, Inbred C57BLMutationNeoplasm MetastasisLiposomesSTING Protein

Stichwörter der Autor:innen

cancer vaccinelipid nanoparticlesliver metastasismRNA deliverypancreatic cancer

Substanzen

Proto-Oncogene Proteins p21(ras)Membrane ProteinsRNA, MessengerLipidsNucleotides, CyclicLiposomescyclic guanosine monophosphate-adenosine monophosphateLipid NanoparticlesSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States.
  • California NanoSystems Institute, University of California, Los Angeles, California 90095, United States.

ORCID-Profile: Xiao Xu, Xiang Wang, Yu-Pei Liao, Lijia Luo, Andre E Nel

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Marlin Miller Jr Family Foundation

Zitieren

APA

Xu, X., Wang, X., Liao, Y. P., Luo, L., & Nel, A. E. (2025). Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano, 19(9), 8579-8594. https://doi.org/10.1021/acsnano.4c14102

Vancouver

Xu X, Wang X, Liao YP, Luo L, Nel AE. Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano. 2025;19(9):8579-8594. doi:10.1021/acsnano.4c14102

BibTeX
@article{Xu2025,
  author = {Xu, Xiao and Wang, Xiang and Liao, Yu-Pei and Luo, Lijia and Nel, Andre E},
  title = {Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {9},
  pages = {8579--8594},
  doi = {10.1021/acsnano.4c14102}
}
Kostenlos starten →